Effects of chloroquine on proliferation and cell cycle of hepatocellular carcinoma cell line HepG2 cultured in vitro

GUAN Ying-hui,LI Xiu-jiang,YANG Qiu-ping,CHI Bao-rong

DOI: https://doi.org/10.13481/j.1671-587x.2009.02.040

2009-01-01

Abstract:Objective: To study the effects of chloroquine on proliferation and cell cycle of hepatocellular carcinoma cell line HepG2 cultured in vitro and provide basis for research on chloroquine in therapy for liver cancer. Methods: HePG2 cells were divided into six groups: control group and chloroquine (8.00, 16.00, 32.00, 64.00 and 128.00 mmol · L-1) groups. The cell viability was determined by MTT, the cell cycle and apoptosis were detected by flow cytometry. Results: Compared with control group, the cell viabilities were inhibited significantly 24 h after treated with chloroquine (32.00-128.00 mmol · L-1) or 48-72 h after treated with chloroquine (8.00-128.00 mmol · L-1) (P< 0.01) and the most obvious inhibitory effect occurred when HepG2 cells were treated with 128.00 mmol · L-1 chloroquine for 72 h (P < 0.01); HepG2 cells treated with chloroquine (32.00-128.00 mmol · L-1) for 24 h were obviously arrested at G2/M phase, compared with control group the percentage of cells at G2/M phase and the apoptotic rate increased with the dose of chloroquine (P < 0.01). Conclusion: Chloroquine can suppress the activity of hepatoma HepG2 cells by inhibiting cell proliferation, inducing apoptosis and arresting cell cycle in vitro. So chloroquine may be used as the drug for treatment of hepatocellular carcinoma.